<p>Naïve WT and MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Rapamycin (~2 μg/mouse) was administered daily from day 4 by the i.p. route. On day 19 post-vaccination, dLNs and spleens were harvested to enumerate percent and total numbers of IL-17 and IFNγ producing CD8<sup>+</sup> T cells <b>(A)</b>. Cohorts of mice were pulsed with BrdU through drinking water from day 7–15. On day 16, dLNs and spleens were harvested to enumerate percent BrdU<sup>+ve</sup> IL-17A and IFNγ producing CD8<sup>+</sup> T cells <b>(B)</b>. Values are the mean ± SD of 4–7 mice/group. *p≤0.05, ***p≤0.001 and ****p≤0.0001. Data is representative of 2 independent experiments.</p
<p>(A), Mice were injected subcutaneously with 4T1-Luc2 cells (5 × 10<sup>5</sup> cells/100 μl PBS/m...
<p>Naïve WT or MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Brd...
<p>Mediastinal lymph nodes from HDM-challenged mice that had or had not been treated with rapamycin ...
<p>EAU induction and rapamycin treatment are described previously. On day 21, the splenocytes were h...
<p>A: absolute lymphocyte number in draining lymph nodes, spleen, and non-draining lymph nodes is de...
T-1 tumor cells. C and D. Proliferation of normal CD3/28 activated splenocytes (pooled from 5 mice) ...
<p>(<b>A</b>) Representative sections of H&E-stained VWAT of Ve- or Rapa-treated mice. Scale bars re...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated for 6 days <i>in vitro</i> wit...
With Rapamycin in vivo for 7 and 20 days (n = 5/group). B and C. Spontaneous apoptosis in splenocyte...
<p>IL-2 complexes were combined with selected agents to alleviate the unintended expansion and activ...
<p>Representative dot plot of flow cytometry analysis of draining lymph nodes for percent of Treg (C...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
<p>B10.RIII mice were treated with or without daily rapamycin (1.5 µg/mouse) as described previously...
<p>(<b>A</b>) CD4<sup>+</sup> FoxP3<sup>+</sup> regulatory T-cells (Tregs) were analyzed in the bloo...
<p>(A), Mice were injected subcutaneously with 4T1-Luc2 cells (5 × 10<sup>5</sup> cells/100 μl PBS/m...
<p>Naïve WT or MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Brd...
<p>Mediastinal lymph nodes from HDM-challenged mice that had or had not been treated with rapamycin ...
<p>EAU induction and rapamycin treatment are described previously. On day 21, the splenocytes were h...
<p>A: absolute lymphocyte number in draining lymph nodes, spleen, and non-draining lymph nodes is de...
T-1 tumor cells. C and D. Proliferation of normal CD3/28 activated splenocytes (pooled from 5 mice) ...
<p>(<b>A</b>) Representative sections of H&E-stained VWAT of Ve- or Rapa-treated mice. Scale bars re...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated for 6 days <i>in vitro</i> wit...
With Rapamycin in vivo for 7 and 20 days (n = 5/group). B and C. Spontaneous apoptosis in splenocyte...
<p>IL-2 complexes were combined with selected agents to alleviate the unintended expansion and activ...
<p>Representative dot plot of flow cytometry analysis of draining lymph nodes for percent of Treg (C...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
<p>B10.RIII mice were treated with or without daily rapamycin (1.5 µg/mouse) as described previously...
<p>(<b>A</b>) CD4<sup>+</sup> FoxP3<sup>+</sup> regulatory T-cells (Tregs) were analyzed in the bloo...
<p>(A), Mice were injected subcutaneously with 4T1-Luc2 cells (5 × 10<sup>5</sup> cells/100 μl PBS/m...
<p>Naïve WT or MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Brd...
<p>Mediastinal lymph nodes from HDM-challenged mice that had or had not been treated with rapamycin ...